Trial Details

COMPLETED
Basic Information
Clinical ID c3130
Identifier NCT02493036
Trial Title A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Irritable Bowel Syndrome With Constipation (IBS-C)
Interventions DRUG: SYN-010
Participant Information
Sponsor Theriva Biologics, Inc.
City Hialeah
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-10
Primary Completion Date 2015-12
Completion Date 2015-12